Ascendis Pharma A (ASND) Research & Development (2016 - 2025)
Historic Research & Development for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to -$91.0 million.
- Ascendis Pharma A's Research & Development fell 737.17% to -$91.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 million, marking a year-over-year increase of 18794.69%. This contributed to the annual value of -$343.1 million for FY2025, which is 459.05% down from last year.
- Per Ascendis Pharma A's latest filing, its Research & Development stood at -$91.0 million for Q4 2025, which was down 737.17% from -$78.2 million recorded in Q3 2025.
- In the past 5 years, Ascendis Pharma A's Research & Development ranged from a high of $121.3 million in Q3 2023 and a low of -$91.0 million during Q4 2025
- Its 5-year average for Research & Development is $60.1 million, with a median of $92.2 million in 2025.
- Per our database at Business Quant, Ascendis Pharma A's Research & Development surged by 26746.48% in 2021 and then tumbled by 18665.48% in 2024.
- Over the past 5 years, Ascendis Pharma A's Research & Development (Quarter) stood at $75.1 million in 2021, then soared by 47.55% to $110.8 million in 2022, then fell by 11.76% to $97.8 million in 2023, then tumbled by 186.65% to -$84.7 million in 2024, then decreased by 7.37% to -$91.0 million in 2025.
- Its Research & Development was -$91.0 million in Q4 2025, compared to -$78.2 million in Q3 2025 and $81.5 million in Q2 2025.